Amid growing concerns over misinformation, a paper accepted for publication is under scrutiny for disseminating inaccurate information about COVID-19 treatment. The authors, previously flagged for similar issues, now face a reevaluation of their manuscript's suitability.
After uncovering insufficient peer review comments and a potential conflict of interest, the editorial team is considering rescinding the decision to publish the manuscript. A decision further complicated by the author's alarming communication about potential interference.
The editorial plan includes contacting the author to request additional peer review and providing them with the subsequent comments. This aligns with COPE advice, emphasizing the journal's authority to ensure the integrity of published content, even post-acceptance. However, given the sensitive nature of the situation, the journal may opt to delay publication rather than rescind acceptance immediately.
Decisions on additional review will hinge on identifying flaws in the original peer review process or the manuscript itself. Factors such as missed fact checks, biased reporting, or ethical concerns may prompt further scrutiny.
As the journal navigates this delicate situation, transparency and adherence to ethical standards remain paramount to uphold the integrity of scientific discourse.